The HPV-DNA Test in Pregnancy: A Review of the Literature.
Zagorianakou N, Mitrogiannis I, Konis K, Makrydimas S, Mitrogiannis L, Makrydimas G.
Cureus. 2023 May 6;15(5):e38619. doi: 10.7759/cureus.38619. eCollection 2023 May.
High-risk human papillomavirus infection in pregnant women: a descriptive analysis of cohorts from two centers.
Liu J, Li Y, Bo D, Wang J, Wang Y.
J Investig Med. 2022 Oct;70(7):1494-1500. doi: 10.1136/jim-2022-002442. Epub 2022 Jun 21.
Efficacy and influencing factors of CO(2) laser, topical photodynamic therapy versus therapy combined with CO(2) laser pretreatment for vaginal low-grade squamous intraepithelial lesions with high-risk HPV infection.
Li Y, Wei Y, Huang J, Gu L, Hong Z, Qiu L.
Photodiagnosis Photodyn Ther. 2024 Apr;46:104017. doi: 10.1016/j.pdpdt.2024.104017. Epub 2024 Feb 16.
Optical Coherence Tomography Can Reduce Colposcopic Referral Rates in Patients With High-Risk Human Papillomavirus.
Xiao X, Yan L, Yang X, Zhou Z, Shi L, Fu C.
J Low Genit Tract Dis. 2023 Oct 1;27(4):324-330. doi: 10.1097/LGT.0000000000000746. Epub 2023 May 3.
Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues.
Balmagambetova S, Tinelli A, Mynbaev OA, Koyshybaev A, Urazayev O, Kereyeva N, Ismagulova E.
Curr Pharm Des. 2020;26(18):2073-2086. doi: 10.2174/1381612826666200422094205.
[Sexuality in adolescents with rheumatic diseases : Contraception, HPV vaccination and pregnancy].
Fischer-Betz R, Haase I, Oommen PT.
Z Rheumatol. 2018 Oct;77(8):667-676. doi: 10.1007/s00393-018-0522-6.
Human papillomavirus infection among women in South and North Vietnam.
Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen Thuy TT, Nguyen HN, Nguyen BD, Ashley R, Snijders PJ, Meijer CJ, Muñoz N, Parkin DM, Franceschi S.
Int J Cancer. 2003 Mar 20;104(2):213-20. doi: 10.1002/ijc.10936.
[Human papilloma virus infection in pregnant women with normal pap-smears, HPV oncogenity and risk factors].
Nowak Z, Karowicz-Bilińska A.
Ginekol Pol. 2007 Sep;78(9):678-84.
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015.
Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.
Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, Sukumaran L, Kharbanda EO.
Obstet Gynecol. 2017 Sep;130(3):599-608. doi: 10.1097/AOG.0000000000002191.
